GILLIS STEVEN — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

GILLIS STEVEN has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

GILLIS STEVEN

Steven Gillis is listed as a Director of Takeda Pharmaceutical Co Ltd in the most recent SEC filing dated 2026-07-06. Beyond this board appointment, the provided SEC context does not include additional biographical details such as education, career history, or prior board roles. This entry is derived solely from the SEC filing context available for analysis.

RoleDirector
Notability60/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-06TAKTAKEDA PHARMACEUTICAL CO LTDA — Grant or award3.8K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is GILLIS STEVEN?

Steven Gillis is listed as a Director of Takeda Pharmaceutical Co Ltd in the most recent SEC filing dated 2026-07-06. Beyond this board appointment, the provided SEC context does not include additional biographical details such as education, career history, or prior board roles. This entry is derived solely from the SEC filing context available for analysis.…

How many SEC Form 4 filings has GILLIS STEVEN submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of GILLIS STEVEN's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live GILLIS STEVEN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.